Cancer Registry  

Cancer Registry: Submitting Data | On-Boarding Process

Population-based cancer surveillance is critical in North America for cancer control activities aimed at reducing the morbidity and mortality of cancer, the second leading cause of death in the United States. Cancer reporting from ambulatory providers to state cancer registries is a new public health objective for Stage 2 Meaningful Use. Reporting to cancer registries by healthcare providers would address current underreporting of cancer, especially certain types. In the past most cancers were diagnosed and/or treated in a hospital setting and data were primarily collected from this source. However, medical practice is changing rapidly and an increasing number of cancer cases are never seen in a hospital. Data collection from providers presents new challenges since the infrastructure for reporting is less mature than it is in hospitals. Certified EHR Technology can address this barrier by identifying reportable cancer cases and treatments to the provider and facilitating electronic reporting either automatically or upon verification by the provider.

Submitting Data or Public Health Meaningful Use

The agency currently accepts electronic submission of an HL7 Clinical Document Architecture (CDA) cancer data message from eligible professionals. Eligible professionals interested in pursuing the cancer Meaningful Use objective may work through the "On-Boarding Process".

The Meaningful Use public health option allows Eligible Professionals (EP) to electronically submit data on cancer using Health Language Seven (HL7) Clinical Document Architecture (CDA).

Meaningful Use Cancer On-Boarding Instructions
Cancer Attestation Process

Contact Email
Cancer Coordinator

Cancer Registry